Literature DB >> 15497521

Nonspecific interstitial pneumonia with poor prognosis associated with amyopathic dermatomyositis.

Noriho Sakamoto1, Hiroshi Mukae, Takeshi Fujii, Sumako Yoshioka, Tomoyuki Kakugawa, Hiroyuki Yamaguchi, Tomayoshi Hayashi, Shigeru Kohno.   

Abstract

Amyopathic dermatomyositis (ADM) is a clinical subtype of dermatomyositis, characterized by the lack of motor weakness and the presence of normal muscle enzyme levels. ADM is sometimes accompanied by interstitial pneumonia that shows a rapid progressive course associated with a poor prognosis. We report a 49-year-old patient who presented with nonspecific interstitial pneumonia (NSIP) associated with ADM. The patient failed to respond to prednisolone and immunosuppressive therapy and died. Although idiopathic NSIP is known to have a better prognosis, NSIP in ADM could be a fatal disease. Therefore, we should appropriately treat interstitial pneumonia in ADM even if it is NSIP.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15497521     DOI： 10.2169/internalmedicine.43.838

Source DB:  PubMed          Journal:  Intern Med        ISSN： 0918-2918            Impact factor:   1.271


  8 in total

1.  Interstitial lung disease in a patient with antisynthetase syndrome and no myositis.

Authors:  Sotiris C Plastiras; Fotini C Soliotis; Panayiotis Vlachoyiannopoulos; George E Tzelepis
Journal:  Clin Rheumatol       Date:  2005-11-23       Impact factor: 2.980

2.  Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.

Authors:  Shuang Ye; Xiao-xiang Chen; Xiao-ye Lu; Mei-fang Wu; Yun Deng; Wen-qun Huang; Qiang Guo; Cheng-de Yang; Yue-ying Gu; Chun-de Bao; Shun-le Chen
Journal:  Clin Rheumatol       Date:  2007-02-17       Impact factor: 2.980

3.  Outcome of patients having dermatomyositis admitted to the intensive care unit.

Authors:  Yaniv Sherer; Daniel Shepshelovich; Tamara Shalev; Yael Haviv; Eran Segal; Michael Ehrenfeld; Yair Levy; Rachel Pauzner; Yehuda Shoenfeld; Pnina Langevitz
Journal:  Clin Rheumatol       Date:  2007-02-27       Impact factor: 2.980

Review 4.  Pneumomediastinum and subcutaneous emphysema secondary to amyopathic dermatomyositis with cryptogenic organizing pneumonia in invasive breast cancer: a case report and review of literature.

Authors:  Sung Hwan Park; Yoon-Seup Kum; Kyung-Chan Kim; Jung-Yoon Choe; Sung-Hoon Park; Seong-Kyu Kim
Journal:  Rheumatol Int       Date:  2008-12-18       Impact factor: 2.631

5.  ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease.

Authors:  Airi Nishimi; Takeo Isozaki; Shinichiro Nishimi; Sho Ishii; Takahiro Tokunaga; Hidekazu Furuya; Kuninobu Wakabayashi; Tsuyoshi Kasama
Journal:  Clin Rheumatol       Date:  2018-02-06       Impact factor: 2.980

Review 6.  Pneumocyte injury and ubiquitin-positive pneumocytes in interstitial lung diseases.

Authors:  Tsutomu Yamada; Yoshinori Kawabata
Journal:  Histopathology       Date:  2014-10-30       Impact factor: 5.087

7.  A Curious Case of Acute Respiratory Failure: Is It Antisynthetase Syndrome?

Authors:  Gurveen Malhotra; Nitya Ramreddy; Serafin Chua; Mira Iliescu; Tanjeev Kaur
Journal:  Case Rep Crit Care       Date:  2016-06-28

8.  Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis.

Authors:  Ting Li; Li Guo; Zhiwei Chen; Liyang Gu; Fangfang Sun; Xiaoming Tan; Sheng Chen; Xiaodong Wang; Shuang Ye
Journal:  Sci Rep       Date:  2016-09-12       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.